Morgan Stanley has announced a new structured investment through a free writing prospectus filed on November 9, 2026. This offering is linked to the common stock of NVIDIA Corporation and is designed to appeal to investors looking for exposure to technology stocks while managing risk.
The investment, termed as "Market Linked Securities—Auto-Callable with Contingent Coupon with Memory Feature and Contingent Downside," allows investors to receive contingent coupon payments based on NVIDIA's stock performance. This innovative approach reflects Morgan Stanley's commitment to providing unique investment solutions in a competitive market.
Company Overview
Morgan Stanley, identified by the Central Index Key 0000895421, operates under the Standard Industrial Classification of 6211, which encompasses Security Brokers, Dealers & Flotation Companies. The firm is publicly traded on the New York Stock Exchange under the ticker symbol MS. As a large accelerated filer, Morgan Stanley has consistently demonstrated its leadership in the financial services industry.
Details from the Filing
The filing, accession number 0001839882-26-055573, outlines the terms of the structured investment, including:
- **Issuer and Guarantor:** Morgan Stanley Finance LLC and Morgan Stanley
- **Underlying Stock:** NVIDIA Corporation common stock
- **Face Amount:** $1,000 per security
- **Contingent Coupon Rate:** At least 12.60% per annum, to be determined on the pricing date
- **Maturity Date:** November 15, 2027
Investors will receive contingent coupon payments if NVIDIA's stock price meets specific thresholds. The structure includes a memory feature that allows for the accumulation of unpaid coupons under certain conditions.
Impact on Stakeholders
This new offering may significantly impact investors looking for innovative ways to invest in technology stocks while managing risk. Additionally, it positions Morgan Stanley against competitors in the security brokerage sector, particularly those also targeting tech-focused investments. The involvement of Wells Fargo Securities, LLC as an agent for this offering indicates collaboration within the industry, potentially enhancing competitive dynamics.
What's Next
The filing does not specify what happens next, but interested investors may expect further details as the pricing date approaches. The market will be watching closely to see how this structured investment performs and its reception among investors.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










